← Back
Data updated: Mar 10, 2026
NOVUGEN
Oncology
NOVUGEN is a generic drug manufacturer focused on Oncology.
2022
Since
5
Drugs
-
Trials
33
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
LENALIDOMIDE 2026-02-02
EVEROLIMUS 2026-01-09
LENALIDOMIDE 2025-11-14
EVEROLIMUS 2025-10-30
LENALIDOMIDE 2025-09-16
PAZOPANIB HYDROCHLORIDE 2025-09-04
EVEROLIMUS 2025-07-21
Labeling
EVEROLIMUS 2025-07-21
Labeling
EVEROLIMUS 2025-07-21
Labeling
LENALIDOMIDE 2025-05-22
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
3 drugs
Pipeline Strength Pro
Loading...
Discontinued (1)
Company Info
- First Approval
- 2022-01-05
- Latest
- 2025-10-30
- Applications
- 5